Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mexican genomics institute plans incubator:

This article was originally published in Clinica

Executive Summary

Mexico's genomic institute, (Inmegen), is considering establishing a commercial incubator. This week, the institute received funding to launch a feasibility study for the project, which seeks to speed up the development of new technologies for use in the national health service, linked to the national bio- and medical technology industries. Inmegen is the result of an alliance involving the health ministry, the national science and technology council, the national autonomous university of Mexico (UNAM) and the Mexican healthcare foundation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057705

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel